Use of sodium selenite as additional treatment in radio-oncelogy -: Clinical phase III study in adjuvant radiotherapy of gynecological cancers

被引：0
|
作者：
Mücke, R
Glatzel, M
Riesenbeck, D
Berndt-Skorka, R
Seifert, G
Schoenekaes, K
Bruns, F
Büntzel, J
Micke, O
机构：
[1] Strahlentherapie Wiesbaden, Wiesbaden, Germany
[2] Zentralklinikum Suhl, Klin Strahlentherapie, Suhl, Germany
[3] Univ Klinikum Musnter, Klin & Poliklin Strahlentherapie Radioonkol, Munster, Germany
[4] Klinikum Chemnitz, Klin Radioonkol, Chemnitz, Germany
来源：
STRAHLENTHERAPIE UND ONKOLOGIE | 2004年 / 180卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：84 / 84
页数：1
相关论文
共 26 条
  • [1] Adjuvant treatment with sodium selenite in gynecologic radiation oncology: First results of a phase III study
    Muecke, R
    Glatzel, M
    Bernd-Skorka, R
    Seifert, G
    Buentzel, J
    Schoenekaes, KG
    Bruns, F
    Kisters, K
    Prott, F
    Micke, O
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2005, 63 (02): : S218 - S219
  • [2] Use of sodium selenite in radiooncology -: Clinical phase III study in the post-operative RT of gynecological tumours -: Study position 11/2004
    Mücke, R
    Micke, O
    Berndt-Skorka, R
    Seifert, G
    Büntzel, J
    Schönekaes, KG
    Bruns, F
    Kisters, K
    Glatzel, W
    STRAHLENTHERAPIE UND ONKOLOGIE, 2005, 181 : 17 - 17
  • [3] Adjuvant treatment with sodium selenite in gynecologic radiation oncology-first results of a phase III study
    Mücke, R
    Glatzel, M
    Bernd-Skorka, R
    Seifert, G
    Büntzel, J
    Schönekaes, KG
    Bruns, F
    Kisters, K
    Micke, O
    RADIOTHERAPY AND ONCOLOGY, 2004, 73 : S167 - S167
  • [4] A CLINICAL PHASE I STUDY ON ADMINISTRATION OF HIGH DOSE SODIUM SELENITE AS A TREATMENT OF CANCER THE SECAR STUDY
    Brodin, Ola
    Wallenberg, Marita
    Misra, Sougat
    Bjornstedt, Mikael
    ANTICANCER RESEARCH, 2014, 34 (10) : 5851 - 5852
  • [5] Pharmacokinetics and Toxicity of Sodium Selenite in the Treatment of Patients with Carcinoma in a Phase I Clinical Trial: The SECAR Study
    Brodin, Ola
    Eksborg, Staffan
    Wallenberg, Marita
    Asker-Hagelberg, Charlotte
    Larsen, Erik H.
    Mohlkert, Dag
    Lenneby-Helleday, Clara
    Jacobsson, Hans
    Linder, Stig
    Misra, Sougat
    Bjornstedt, Mikael
    NUTRIENTS, 2015, 7 (06): : 4978 - 4994
  • [6] Raltitrexed and radiotherapy as adjuvant treatment for stage II-III rectal cancer: A phase II study.
    Draghini, L.
    Lupattelli, M.
    Bellavita, R.
    Maranzano, E.
    Beneventi, S.
    D'Ambrosio, M. S.
    Trippa, F.
    Aristei, C.
    RADIOTHERAPY AND ONCOLOGY, 2006, 81 : S240 - S241
  • [7] Phase I study of oxaliplatin in combination with capecitabine and radiotherapy as adjuvant treatment for stage II and III rectal cancer
    Jin, J.
    Li, Y. X.
    Wang, W. H.
    Liu, Y. P.
    Wang, K.
    Fang, H.
    Zhou, Z. X.
    Zhou, A. P.
    Wang, J. W.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2007, 69 (03): : S284 - S285
  • [8] A randomized phase III clinical trial of a combined treatment for cachexia in patients with gynecological cancers: Evaluating the impact on metabolic and inflammatory profiles and quality of life
    Maccio, Antonio
    Madeddu, Clelia
    Gramignano, Giulia
    Mulas, Carlo
    Floris, Carlo
    Sanna, Eleonora
    Cau, Maria Chiara
    Panzone, Filomena
    Mantovani, Giovanni
    GYNECOLOGIC ONCOLOGY, 2012, 124 (03) : 417 - 425
  • [9] Tumor regression grading after preoperative hyperfractionated radiotherapy/chemoradiotherapy for locally advanced rectal cancers: A phase III clinical study
    Idasiak, A.
    Galwas-Kliber, K.
    Behrendt, K.
    Wzietek, I.
    Zeman, M.
    Stobiecka, E.
    Chmielik, E.
    Dworzecki, T.
    Suwinski, R.
    ANNALS OF ONCOLOGY, 2018, 29
  • [10] Nimotuzumab and radiotherapy for treatment of newly diagnosed diffuse intrinsic pontine glioma (DIPG): a phase III clinical study
    Fleischhack, G.
    Massimino, M.
    Warmuth-Metz, M.
    Khuhlaeva, E.
    Janssen, G.
    Graf, N.
    Rutkowski, S.
    Beilken, A.
    Schmid, I.
    Biassoni, V.
    Gorelishev, S. K.
    Kramm, C.
    Reinhard, H.
    Schlegel, P. G.
    Kortmann, R. -D.
    Reuter, D.
    Bach, F.
    Iznaga-Escobar, N. E.
    Bode, U.
    JOURNAL OF NEURO-ONCOLOGY, 2019, 143 (01) : 107 - 113
123